Les cancers du poumon à petites cellules = Small cell lung carcinomaBENNOUNA, Jaafar; DOUILLARD, Jean-Yves.Concours médical (Paris). 2002, Vol 124, Num 29, pp 1889-1893, issn 0010-5309, 5 p.Article

Small cell carcinoma of the esophagus: Analysis of 10 cases and review of the published dataBENNOUNA, Jaafar; BARDET, Etienne; DEGUIRAL, Philippe et al.American journal of clinical oncology. 2000, Vol 23, Num 5, pp 455-459, issn 0277-3732Article

Impact of histology on survival of resected non-small cell lung cancer (NSCLC) receiving adjuvant chemotherapy: Subgroup analysis of the adjuvant vinorelbine (NVB) cisplatin (CDDP) versus observation in the ANITA trialBENNOUNA, Jaafar; SENELLART, Helene; HIRET, Sandrine et al.Lung cancer. 2011, Vol 74, Num 1, pp 30-34, issn 0169-5002, 5 p.Article

Resection of hepatic and pulmonary metastases in patients with colorectal cancerHAMY, Antoine; BARON, Olivier; BENNOUNA, Jaffar et al.American journal of clinical oncology. 2001, Vol 24, Num 6, pp 607-609, issn 0277-3732Article

Subcutaneous interleukin-2 and interferon α in the treatment of patients with metastatic renal cell carcinoma-less efficacy compared with intravenous interleukin-2 and interferon α: Results of a multicenter phase II trial from the Groupe Français d'ImmunothérapieRAVAUD, Alain; DELVA, Rémy; GOMEZ, Fréderic et al.Cancer. 2002, Vol 95, Num 11, pp 2324-2330, issn 0008-543X, 7 p.Article

Can interleukin-2 reverse anthracyclin chemoresistance in metastatic soft tissue sarcoma patients. Results of a prospective phase II clinical trialGRAVIS, Gwenaelle; MOUSSEAU, Mireille; DOUILLARD, Jean-Yves et al.European cytokine network (Montrouge). 2001, Vol 12, Num 2, pp 239-243, issn 1148-5493Article

Treatment of patients with metastatic renal carcinoma with a combination of subcutaneous interleukin-2 and interferon alfa with or without fluorouracilNEGRIER, Sylvie; CATY, Armelle; LESIMPLE, Thierry et al.Journal of clinical oncology. 2000, Vol 18, Num 24, pp 4009-4015, issn 0732-183XArticle

Prognostic factors of response or failure of treatment in patients with metastatic renal carcinomas treated by cytokines : a report from the Groupe Français d'immunothérapieNEGRIER, Sylvie; GOMEZ, Frédéric; DOUILLARD, Jean-Yves et al.World journal of urology (Print). 2005, Vol 23, Num 3, pp 161-165, issn 0724-4983, 5 p.Article

Mutant KRAS Codon 12 and 13 Alleles in Patients With Metastatic Colorectal Cancer: Assessment As Prognostic and Predictive Biomarkers of Response to PanitumumabPEETERS, Marc; DOUILLARD, Jean-Yves; VAN CUTSEM, Eric et al.Journal of clinical oncology. 2013, Vol 31, Num 6, pp 759-765, issn 0732-183X, 7 p.Article

Optimisation du bon usage et maîtrise des coûts des médicaments anticancéreux: expérience de l'Observatoire dédié au Cancer Bretagne ― Pays-de-la-Loire = Optimizing good use and costs of anticancer drugs: A French inter regional study of the Observatory of CancerGRUDE, Françoise; BESSARD, Réjane; BOURGEOIS, Hugues et al.Bulletin du cancer. 2013, Vol 100, Num 3, pp 271-282, issn 0007-4551, 12 p.Article

Tumeur carcinoïde au stade métastatique : intérêt toujours d'actualité de la thérapie à la miBG-I131 = Radiation therapy with ¹³¹I-MIBG is still relevant for metastatic carcinoid tumorsOUDOUX, Aurore; BRIDJI, Boumédiène; RESCHE, Isabelle et al.Gastroentérologie clinique et biologique. 2005, Vol 29, Num 8-9, pp 935-938, issn 0399-8320, 4 p.Article

Interleukine-2 et Interféron dans le cancer du rein métastatique. L'expérience du Groupe Français d'Immunothérapie. Commentaire = Interleukin-2 and interferon in metastatic renal cancer. The French Immunotherapy Group experience. CommentaryNEGRIER, Sylvie; DOUILLARD, Jean-Yves; GOMEZ, Frédéric et al.Progrès en urologie (Paris). 2002, Vol 12, Num 2, pp 213-218, issn 1166-7087Article

ERCC1 Isoform Expression and DNA Repair in Non―Small-Cell Lung CancerFRIBOULET, Luc; OLAUSSEN, Ken André; FILIPITS, Martin et al.The New England journal of medicine. 2013, Vol 368, Num 12, pp 1101-1110, issn 0028-4793, 10 p.Article

Panitumumab―FOLFOX4 Treatment and RAS Mutations in Colorectal CancerDOUILLARD, Jean-Yves; OLINER, Kelly S; RIVERA, Fernando et al.The New England journal of medicine. 2013, Vol 369, Num 11, pp 1023-1034, issn 0028-4793, 12 p.Article

Phase III Trial Comparing Vinflunine With Docetaxel in Second-Line Advanced Non-Small-Cell Lung Cancer Previously Treated With Platinum-Containing ChemotherapyKRZAKOWSKI, Maciej; RAMLAU, Rodryg; DELGADO, François M et al.Journal of clinical oncology. 2010, Vol 28, Num 13, pp 2167-2173, issn 0732-183X, 7 p.Article

Potential Regional Differences for the Tolerability Profiles of FluoropyrimidinesHOLLER, Daniel G; CASSIDY, Jim; BERTINO, Joseph R et al.Journal of clinical oncology. 2008, Vol 26, Num 13, pp 2118-2123, issn 0732-183X, 6 p.Article

Randomized phase II feasibility study of combining the matrix metalloproteinase inhibitor BMS-275291 with paclitaxel plus carboplatin in advanced non-small cell lung cancerDOUILLARD, Jean-Yves; PESCHEL, Christian; HUMPHREY, Jeffrey et al.Lung cancer. 2004, Vol 46, Num 3, pp 361-368, issn 0169-5002, 8 p.Article

Recent issues in first-line treatment of advanced non-small-cell lung cancer: Results of an International Expert Panel Meeting of the Italian Association of Thoracic OncologyGRIDELLI, Cesare; ARDIZZONI, Andrea; DI MAIOF, Massimo et al.Lung cancer. 2010, Vol 68, Num 3, pp 319-331, issn 0169-5002, 13 p.Article

Randomized, Phase III Trial of Panitumumab With Infusional Fluorouracil, Leucovorin, and Oxaliplatin (FOLFOX4) Versus FOLFOX4 Alone As First-Line Treatment in Patients With Previously Untreated Metastatic Colorectal Cancer: The PRIME StudyDOUILLARD, Jean-Yves; SIENA, Salvatore; RIVERA, Fernando et al.Journal of clinical oncology. 2010, Vol 28, Num 31, pp 4697-4705, issn 0732-183X, 9 p.Article

Molecular Predictors of Outcome With Gefitinib and Docetaxel in Previously Treated Non―Small-Cell Lung Cancer: Data From the Randomized Phase III INTEREST TrialDOUILLARD, Jean-Yves; SHEPHERD, Frances A; WATKINS, Claire L et al.Journal of clinical oncology. 2010, Vol 28, Num 5, pp 744-752, issn 0732-183X, 9 p.Article

Efficacy of Oxaliplatin Plus Capecitabine or Infusional Fluorouracil/Leucovorin in Patients With Metastatic Colorectal Cancer : A Pooled Analysis of Randomized TrialsARKENAU, Hendrik-Tobias; ARNOLD, Dirk; SCHMOLL, Hans-Joachim et al.Journal of clinical oncology. 2008, Vol 26, Num 36, pp 5910-5917, issn 0732-183X, 8 p.Article

Cisplatin in combination with either gemcitabine or irinotecan in carcinomas of unknown primary site: Results of a randomized phase II study: Trial for the French Study Group on Carcinomas of Unknown Primary (GEFCAPI 01)CULINE, Stéphane; LORTHOLARY, Alain; DOUILLARD, Jean-Yves et al.Journal of clinical oncology. 2003, Vol 21, Num 18, pp 3479-3482, issn 0732-183X, 4 p.Article

Pooled Analysis of the Prognostic and Predictive Effects of KRAS Mutation Status and KRAS Mutation Subtype in Early-Stage Resected Non-Small-Cell Lung Cancer in Four Trials of Adjuvant ChemotherapySHEPHERD, Frances A; DOMERG, Caroline; BOURREDJEM, abderrahmane et al.Journal of clinical oncology. 2013, Vol 31, Num 17, pp 2173-2181, issn 0732-183X, 9 p.Article

Multifactorial pharmacogenetic analysis in colorectal cancer patients receiving 5-fluorouracil- based therapy together with cetuximab-irinotecanETIENNE-GRIMALDI, Marie-Christine; BENNOUNA, Jaafar; JACOB, Jacques-Henri et al.British journal of clinical pharmacology. 2012, Vol 73, Num 5, pp 776-785, issn 0306-5251, 10 p.Article

Changes in Tumor Density in Patients with Advanced Hepatocellular Carcinoma Treated with SunitinibFAIVRE, Sandrine; ZAPPA, Magaly; DOKMAK, Safi et al.Clinical cancer research (Print). 2011, Vol 17, Num 13, pp 4504-4512, issn 1078-0432, 9 p.Article